APA (7th ed.) Citation

RK, S., P, J., GJ, C., MM, R., PC, O., TY, T., . . . JS, F. (2025). The Mac1 ADP-ribosylhydrolase is a therapeutic target for SARS-CoV-2. ELife, 14, . https://doi.org/10.7554/eLife.103484

Chicago Style (17th ed.) Citation

RK, Suryawanshi, et al. "The Mac1 ADP-ribosylhydrolase Is a Therapeutic Target for SARS-CoV-2." ELife 14 (2025). https://doi.org/10.7554/eLife.103484.

MLA (9th ed.) Citation

RK, Suryawanshi, et al. "The Mac1 ADP-ribosylhydrolase Is a Therapeutic Target for SARS-CoV-2." ELife, vol. 14, 2025, https://doi.org/10.7554/eLife.103484.